Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol...and what if IND is approved?...big time gap up!
Who else could have assembled this Mgmt/BOD/Advisory?
Lol...there is no pumping...waggs is only updating shareholders on where we stand regarding IND...go reread the last few prs...its silly to say it's a pump...
https://ir.pharmacyte.com/press-releases
Yes...more and more investors will start spreading the word...big boys dont want it to move so quick yet until they are finished buying...holding my shares.
This is true...just goes to show you how the MMs use their privileges to influence pps...only 13k shares were traded in pre-market to push pps to .024...so when some investors see this they just sell ASAP.
It was all coordinated to get some cheap shares... you could see it happening the pre market.
Shake it...shake it...shake it
For anyone new to the stock...
"With over 40 peer reviewed publications the Cell-in-a-Box technology has shown great promise in the areas of cancer, diabetes and drug delivery research1-7. For example, in cases of localized cancerous tumors it is desirable to deliver localized treatment. To affect a localized treatment for pancreatic cancer, Cell-in-a-Box encapsulated cells were placed, using selective catheterization, into blood vessels leading to the tumor1. These cells locally converted a chemotherapeutic prodrug to its tumor toxic form. This treatment improved the 1-year survival rate from 11% to 36%. This localized treatment research is ongoing and may result in significant improvements in the treatment of pancreatic cancer."
Sigma Aldrich markets cell in box test kits
https://www.sigmaaldrich.com/technical-documents/articles/biology/cell-in-a-box.html
You are correct...waggs did mention in the last CC that pmcb is set up as a Nasdaq stock having a BOD...
Shares are increasingly being put into stronger hands...when IND approval is given...the gap up could be enormous.
I think the next CC will be held to announce IND approval and what's to come...
I hear you basset1...a long time coming. Patience hopefully goes a long way...I believe in this technology and will see it to the end.
20mil shares in first hour...bigger run coming as IND approval is nearing
Impressive volume so far....
A new week...let's get some good news.
If someone sells at .005 and the stock goes to .0224 then that's on that person...especially when the company is in the midst of trying to get an IND approved by FDA...I believe in this technology and did not sell at that low pps...the IND is on hold not rejected...if someone sells while relying on other investors opinions then again...its on you. When the right news hits...we could be back at that .62...in a flash!
No one really cares about 5 years ago...what is important is where we are today...pmcb is closer than ever to having a clinical phase 2b trial for an unmet need in pancreatic cancer...all pmcb has to do is supply the information requested by fda to get this groundbreaking technology in gear and then boom...
There are lots of longs out there...we are patiently waiting for the big news...it will come...for those who think big pharma isnt taking notice of cell in box and the potential it has to save lives then they will miss out...big pharmas are very interested in new technologies especially when aimed at an unmet need...once the clinical starts...a play could very well be made for this technology...matter of fact...it is very possible a conditional offer could be on the table.
I haven't seen any pumps...
Yeah...a scam that filed an IND and is now supplying more info so FDA can approved a phase 2b clinical trial...
Will we get news tomorrow...
Somebodies knows something...
All that does not matter...what does matter is the IND is filed and FDA would like more info...that's it...nothing else matters at this point...just be ready when pmcb satisfies FDA requests...pps will skyrocket as pmcb will be given permission to start a phase 2b clinical for an unmet need in pancreatic cancer...then the buyout rumors will begin.
It's a scam that's ready to jump to a buck when FDA gives the go ahead for an IND for a phase 2b for an unmet need in pancreatic cancer...instant buyout target!...be ready!
Yeah...ok...as cell in box moves forward.
So it seems Austrianova is setting itself up for a buyout now that they have the FDA FEI?...if so cell in box for pancreatic cancer could be packaged along....one big huge buyout!
Hmmm...a 2mil share buy went by.
I will believe Austrianova when they say it's a "Big Whoop"...
Yes Brian a sometimes long and frustrating road for this young startup bio...many obstacles had/have to be dealt with along the way and for investors lots of patience is required...glad you are still checking in every once in a while. Good luck to you as well.
I just luv that last sentence wolfy3...
Austrianova announced today that it has received a United States of America (US) Food and Drug Administration (FDA) Establishment Identifier (FEI) number for its Good Manufacturing Production (GMP) manufacturing facility in Thailand. An FEI number is a mandatory requirement for manufacturers and distributors who plan to market their products in the USA. Facilities that manufacture Active Pharmaceutical Ingredient, cell therapy products and Finished Dosage Forms, like Austrianova need FEI registration. In addition to the FEI, Austrianova already has a D-U-N-S Number, which is a copyrighted proprietary means of identifying business entities on a location specific basis, another requirement by the US FDA.
Rahul Pawa, Austrianova’s Chief Production Officer, stated “We are pleased to announce this important step in compliance with the US FDA requirements. We already announced some months ago that we filed a Drug Master File with the US FDA for encapsulated cell products. This moves us further along on our path to commercial products in the US.”
Oh....thanks for the repost. It's totally possible.
Dont ask me...ask the poster who posted this last night...lol
Yep...coming from someone who sez Pfizer bought a large position in pmcb...
Hmmm..ok...even though pmcb has filed an IND with the FDA for a phase 2b clinical trial for an unmet need for pancreatic cancer.
Where is the pump...we are only getting progress reports.
Dr. Hidalgo commented, “With PharmaCyte proceeding with the GMP production of the clinical trial product for its LAPC trial, I am more excited than ever to be a part of PharmaCyte’s clinical trial team. I remain enthusiastic about being the PI for the trial. I am also optimistic about the potential that PharmaCyte’s treatment may hold for patients suffering from LAPC and possibly other types of solid cancerous tumors. For example, PharmaCyte’s therapy for cancers involving the pancreas, liver and breast may offer an effective way to specifically target those cancers with little to no side effects from the chemotherapy.”
"With over 40 peer reviewed publications the Cell-in-a-Box technology has shown great promise in the areas of cancer, diabetes and drug delivery research. For example, in cases of localized cancerous tumors it is desirable to deliver localized treatment. To affect a localized treatment for pancreatic cancer, Cell-in-a-Box encapsulated cells were placed, using selective catheterization, into blood vessels leading to the tumor. These cells locally converted a chemotherapeutic prodrug to its tumor toxic form. This treatment improved the 1-year survival rate from 11% to 36%. This localized treatment research is ongoing and may result in significant improvements in the treatment of pancreatic cancer."
https://www.sigmaaldrich.com/technical-documents/articles/biology/cell-in-a-box.html
I am on board with this...cell in box is a ground breaking technology and it's now on FDA doorstep.